Continuing Medical Education - CME Courses

Popular

• • 

    

    Jürgen Floege, MD

    Peer

  • 

    

    Jonathan Barratt, PhD

    Peer

  • 

    

    David Jayne, MD

    Peer

  9

  

  RestartResume

  Updates in Glomerular Disease

  Updates in Glomerular Disease

  0.50 credits

• • 

    

    Javed Butler, MD, MBA, MPH

    Peer

  • 

    

    Ileana L. Piña, MD, MPH, FAHA, FACC

    Peer

  • 

    

    Patrick Rossignol, MD, PhD

    Peer

  4

  

  RestartResume

  Don’t Let Hyperkalemia Get You Down When Potassium Goes Up in Your Patients with Heart Failure

  Don’t Let Hyperkalemia Get You Down When Potassium Goes Up in Your Patients with Heart Failure

  0.25 credits

• • 

    

    Mark A. Atkinson, PhD

    Peer

  • 

    

    Linda DiMeglio, MD, MPH

    Peer

  3

  

  RestartResume

  Predicting Type 1 Diabetes Using Genetic Testing or Islet Antibody Screening: Are WE There Yet?

  Predicting Type 1 Diabetes Using Genetic Testing or Islet Antibody Screening: Are WE There Yet?

  0.50 credits

• • 

    

    Christina Y. Weng, MD, MBA

    Peer

  • 

    

    Glenn Yiu, MD, PhD

    Peer

  0

  

  RestartResume

  Diabetic Eye Disease Pipeline Therapies Part 2: High-dose Aflibercept & Gene Therapy

  Diabetic Eye Disease Pipeline Therapies Part 2: High-dose Aflibercept & Gene Therapy

  0.50 credits

• • 

    

    Christina Y. Weng, MD, MBA

    Peer

  • 

    

    Basil K. Williams Jr, MD

    Peer

  0

  

  RestartResume

  Wet AMD Pipeline Therapies Part 3: KSI-301 and GB-102

  Wet AMD Pipeline Therapies Part 3: KSI-301 and GB-102

  0.50 credits

• • 

    

    Danielle Becker, MD, MS, FAES

    Peer

  • 

    

    Ahmed Abdelmoity, MD

    Peer

  • 

    

    Deborah Holder, MD

    Peer

  • 

    

    John Stern, MD

    Peer

  2

  

  RestartResume

  Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes

  Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes

  0.25 credits

• • 

    

    Christina Y. Weng, MD, MBA

    Peer

  • 

    

    Sophie J. Bakri, MD

    Peer

  1

  

  RestartResume

  Diabetic Eye Disease Pipeline Therapies Part 3: Brolucizumab & PDS

  Diabetic Eye Disease Pipeline Therapies Part 3: Brolucizumab & PDS

  0.50 credits

• • 

    

    Christina Y. Weng, MD, MBA

    Peer

  • 

    

    Peter A. Campochiaro, MD

    Peer

  1

  

  RestartResume

  Wet AMD Pipeline Therapies Part 2: PDS and RGX-314

  Wet AMD Pipeline Therapies Part 2: PDS and RGX-314

  0.75 credits

• • 

    

    Caron A. Jacobson, MD

    Peer

  2

  

  RestartResume

  Paradigm Shifts in CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma:  A Video Viewpoint

  Paradigm Shifts in CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma:  A Video Viewpoint

  0.25 credits

• • 

    

    Hope S. Rugo, MD, FASCO

    Peer

  • 

    

    Adam M. Brufsky, MD, PhD

    Peer

  1

  

  Metastatic Breast Cancer: Applying Real-World Evidence to Enhance Shared Decision-Making

  0.75 credits 3 episodes

• • 

    

    Caron A. Jacobson, MD

    Peer

  • 

    

    Matthew Lunning, DO

    Peer

  • 

    

    Loretta J. Nastoupil, MD

    Peer

  0

  

  RestartResume

  Paradigm Shifts in CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: A Video Panel Discussion

  Paradigm Shifts in CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: A Video Panel Discussion

  0.50 credits

• • 

    

    Cihan Ay, MD

    Peer

  • 

    

    Jean M. Connors, MD

    Peer

  • 

    

    Alok A. Khorana, MD

    Peer

  3

  

  RestartResume

  How Do We Make Sense of Guidelines and Apply to Our Everyday Practice?

  How Do We Make Sense of Guidelines and Apply to Our Everyday Practice?

  1.00 program credits

• • 

    

    Hope S. Rugo, MD, FASCO

    Peer

  • 

    

    Adam M. Brufsky, MD, PhD

    Peer

  1

  

  RestartResume

  Interpretation and Application of RWE to Inform Shared Decision-Making in Metastatic HR+ Breast Cancer

  Interpretation and Application of RWE to Inform Shared Decision-Making in Metastatic HR+ Breast Cancer

  0.75 program credits

• • 

    

    Cihan Ay, MD

    Peer

  4

  

  RestartResume

  Treatment of a Patient With Cancer and With Catheter-Related Thrombosis

  Treatment of a Patient With Cancer and With Catheter-Related Thrombosis

  1.00 program credits

• • 

    

    Jean M. Connors, MD

    Peer

  2

  

  RestartResume

  Treatment of Patient With Low Risk of Gastrointestinal Absorption Impairment for Established VTE With Cancer

  Treatment of Patient With Low Risk of Gastrointestinal Absorption Impairment for Established VTE With Cancer

  1.00 program credits